Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700029120

Trial Profile

Clinical Trials Insight: 700029120

Status: Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 18 Oct 2010

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nabiximols (Primary)
  • Indications Multiple sclerosis; Muscle spasticity
  • Focus Registrational; Therapeutic Use
  • Sponsors GW Pharmaceuticals
  • Most Recent Events

    • 14 Oct 2010 According to an Almirall media release, results from 3 pivotal clinical studies of tetrahydrocannabinol/cannabidiol (Sativex) were presented in a satellite symposium at the 26th annual congress of the ECTRIMS.
    • 12 Sep 2009 Results presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS).
    • 09 Sep 2009 Primary endpoint 'Improvement in symptoms' has been met.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top